220 related articles for article (PubMed ID: 29209431)
1. Combining cytogenetic and epigenetic approaches in chronic lymphocytic leukemia improves prognosis prediction for patients with isolated 13q deletion.
Bagacean C; Le Dantec C; Berthou C; Tempescul A; Saad H; Bordron A; Zdrenghea M; Cristea V; Douet-Guilbert N; Renaudineau Y
Clin Epigenetics; 2017; 9():122. PubMed ID: 29209431
[TBL] [Abstract][Full Text] [Related]
2. Genomic aberrations and survival in chronic lymphocytic leukemia.
Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P
N Engl J Med; 2000 Dec; 343(26):1910-6. PubMed ID: 11136261
[TBL] [Abstract][Full Text] [Related]
3. Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance.
Van Damme M; Crompot E; Meuleman N; Maerevoet M; Mineur P; Bron D; Lagneaux L; Stamatopoulos B
Clin Epigenetics; 2016; 8():132. PubMed ID: 27980696
[TBL] [Abstract][Full Text] [Related]
4. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
[TBL] [Abstract][Full Text] [Related]
5. Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study.
Bigoni R; Cuneo A; Roberti MG; Bardi A; Rigolin GM; Piva N; Scapoli G; Spanedda R; Negrini M; Bullrich F; Veronese ML; Croce CM; Castoldi G
Leukemia; 1997 Nov; 11(11):1933-40. PubMed ID: 9369429
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
[TBL] [Abstract][Full Text] [Related]
7. 13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia.
Dal Bo M; Rossi FM; Rossi D; Deambrogi C; Bertoni F; Del Giudice I; Palumbo G; Nanni M; Rinaldi A; Kwee I; Tissino E; Corradini G; Gozzetti A; Cencini E; Ladetto M; Coletta AM; Luciano F; Bulian P; Pozzato G; Laurenti L; Forconi F; Di Raimondo F; Marasca R; Del Poeta G; Gaidano G; Foà R; Guarini A; Gattei V
Genes Chromosomes Cancer; 2011 Aug; 50(8):633-43. PubMed ID: 21563234
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic characteristics of B cell chronic lymphocytic leukemia in 275 Chinese patients by fluorescence in situ hybridization: a multicenter study.
Lai YY; Huang XJ
Chin Med J (Engl); 2011 Aug; 124(16):2417-22. PubMed ID: 21933580
[TBL] [Abstract][Full Text] [Related]
9. Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcome.
Puiggros A; Venturas M; Salido M; Blanco G; Fernandez-Rodriguez C; Collado R; Valiente A; Ruiz-Xivillé N; Carrió A; Ortuño FJ; Luño E; Calasanz MJ; Ardanaz MT; Piñán MÁ; Talavera E; González MT; Ortega M; Marugán I; Ferrer A; Gimeno E; Bellosillo B; Delgado J; Hernández JÁ; Hernández-Rivas JM; Espinet B; ;
Genes Chromosomes Cancer; 2014 Sep; 53(9):788-97. PubMed ID: 24915757
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia.
Van Dyke DL; Shanafelt TD; Call TG; Zent CS; Smoley SA; Rabe KG; Schwager SM; Sonbert JC; Slager SL; Kay NE
Br J Haematol; 2010 Feb; 148(4):544-50. PubMed ID: 19895615
[TBL] [Abstract][Full Text] [Related]
11. Chronic lymphocytic leukaemia profiled for prognosis using a fluorescence in situ hybridisation panel.
Reddy KS
Br J Haematol; 2006 Mar; 132(6):705-22. PubMed ID: 16487171
[TBL] [Abstract][Full Text] [Related]
12. Influence of clone and deletion size on outcome in chronic lymphocytic leukemia patients with an isolated deletion 13q in a population-based analysis in British Columbia, Canada.
Huang SJ; Gillan TL; Gerrie AS; Hrynchak M; Karsan A; Ramadan K; Smith AC; Toze CL; Bruyere H
Genes Chromosomes Cancer; 2016 Jan; 55(1):16-24. PubMed ID: 26391112
[TBL] [Abstract][Full Text] [Related]
13. Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemia.
Bagacean C; Tempescul A; Le Dantec C; Bordron A; Mohr A; Saad H; Olivier V; Zdrenghea M; Cristea V; Cartron PF; Douet-Guilbert N; Berthou C; Renaudineau Y
Oncotarget; 2017 Sep; 8(39):65699-65716. PubMed ID: 29029465
[TBL] [Abstract][Full Text] [Related]
14. Characterizing patients with multiple chromosomal aberrations detected by FISH in chronic lymphocytic leukemia.
González-Gascón Y Marín I; Hernández-Sanchez M; Rodríguez-Vicente AE; Puiggros A; Collado R; Luño E; González T; Ruiz-Xivillé N; Ortega M; Gimeno E; Muñoz C; Infante MS; Delgado J; Vargas MT; González M; Bosch F; Espinet B; Hernández-Rivas JM; Hernández JÁ;
Leuk Lymphoma; 2018 Mar; 59(3):633-642. PubMed ID: 28728469
[TBL] [Abstract][Full Text] [Related]
15. The influence of different chromosomal aberrations on molecular cytogenetic parameters in chronic lymphocytic leukemia.
Amiel A; Leopold L; Gronich N; Yukla M; Fejgin MD; Lishner M
Cancer Genet Cytogenet; 2006 Jun; 167(2):145-9. PubMed ID: 16737914
[TBL] [Abstract][Full Text] [Related]
16. A higher percentage of cells with 13q deletion predicts worse outcome in Chinese patients with chronic lymphocytic leukemia carrying isolated 13q deletion.
Miao Y; Miao Y; Shi K; Sun Q; Zhao SS; Xia Y; Qin SC; Qiu HR; Yang H; Xu H; Zhu HY; Wu JZ; Wu W; Cao L; Wang L; Fan L; Xu W; Li JY
Ann Hematol; 2018 Sep; 97(9):1663-1669. PubMed ID: 29736587
[TBL] [Abstract][Full Text] [Related]
17. [Fluorescence in Situ Hybridization for Detecting Molecular Cytogenetic Abnormalities of Chronic Lymphocytic Leukemia].
Zhang HY; Yang YL; Zhao Q; Zhang J; Bai H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1474-1479. PubMed ID: 33067940
[TBL] [Abstract][Full Text] [Related]
18. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia.
Fabbri M; Bottoni A; Shimizu M; Spizzo R; Nicoloso MS; Rossi S; Barbarotto E; Cimmino A; Adair B; Wojcik SE; Valeri N; Calore F; Sampath D; Fanini F; Vannini I; Musuraca G; Dell'Aquila M; Alder H; Davuluri RV; Rassenti LZ; Negrini M; Nakamura T; Amadori D; Kay NE; Rai KR; Keating MJ; Kipps TJ; Calin GA; Croce CM
JAMA; 2011 Jan; 305(1):59-67. PubMed ID: 21205967
[TBL] [Abstract][Full Text] [Related]
19. Chronic lymphocytic leukemia with del13q14 as the sole abnormality: dynamic prognostic estimate by interphase-FISH.
Orlandi EM; Bernasconi P; Pascutto C; Giardini I; Cavigliano PM; Boni M; Zibellini S; Cazzola M
Hematol Oncol; 2013 Sep; 31(3):136-42. PubMed ID: 23060227
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin heavy chain (IGH@) translocations negatively impact treatment-free survival for chronic lymphocytic leukemia patients who have an isolated deletion 13q abnormality.
Gerrie AS; Bruyere H; Chan MJ; Dalal CB; Ramadan KM; Huang SJ; Toze CL; Gillan TL
Cancer Genet; 2012 Oct; 205(10):523-7. PubMed ID: 22939229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
